Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-life Study to Assess the Incidence of Allergic Manifestations and Infectious Episodes in Healthy Term Infants at Risk of Dysbiosis During the First Year of Life

NCT04182425 is registered in ClinicalTrials.gov with Bledina as lead sponsor.

NCT NCT04182425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04182425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-life Study to Assess the Incidence of Allergic Manifestations and Infectious Episodes in Healthy Term Infants at Risk of Dysbiosis During the First Year of Life
Lead sponsor
Bledina
Phase
Observational
Overall status
Completed
Start date
December 7, 2019
Completion date
July 4, 2022
Enrollment
334 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermatitis, allergic contact, infectious diseases